英夫利西单抗治疗类风湿关节炎和强直性脊柱炎的参考意见
被引量:7
摘要
类风湿关节炎(RA)和强直性脊柱炎(AS)是一种病因%未完全阐明的炎性疾病,在其发病过程中,TNFα等炎性因产扮演了至关重要的角色。
出处
《中华内科杂志》
CAS
CSCD
北大核心
2012年第12期1011-1016,共6页
Chinese Journal of Internal Medicine
参考文献60
-
1SmolenJ S, Aletaha D, BiJ lsmaJ W, et al. Treating rheumatoid arthritis to target: recommendations of an international task force. Ann Rheum Dis,2010,69:631-637.
-
2强直性脊柱炎诊断及治疗指南[J].中华风湿病学杂志,2010,14(8):557-559. 被引量:846
-
3BraunJ , van den Berg R, Baraliakos X, et al. 20 10 update of the ASAS/EULAR recommendations forthe management of ankylosing spondylitis. Ann Rheum Dis,2011 ,70:896-904.
-
4Aletaha D, Neogi T, Silman AJ , et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatologyl European League Against Rheumatism collaborative initiative. Arthritis Rheum, 20 10 ,62 : 2569-2581.
-
5Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum,1988,31 :315-324.
-
6类风湿关节炎诊断及治疗指南[J].中华风湿病学杂志,2010,14(4):265-270. 被引量:1276
-
7SinghJ A, Furst DE, Bharat A, et al. 2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis. Arthritis Care Res (Hoboken) , 2012,64 :625-639.
-
8Visser K, Goekoop-Ruiterman YP, de Vries-BouwstraJ K,et al. A matrix risk model for the prediction of rapid radiographic progression in patients with rheumatoid arthritis receiving different dynamic treatment strategies: post hoc analyses from the BeSt study. Ann Rheum Dis,2010,69:1333-1337.
-
9Furst DE, Keystone EC, BraunJ , et al. Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2011. Ann Rheum Dis,2012,71 SuppI2:i245.
-
10van der HeiJ de D, SieperJ , Maksymowych WP , et al. 2010 Update of the international ASAS recommendations for the use of anti-TNF agents in patients with axial spondyloarthritis. Ann Rheum Dis, 2011,70:905-908.
二级参考文献25
-
1中华医学会肝病学分会,中华医学会感染病学分会.慢性乙型肝炎防治指南[J].中华流行病学杂志,2006,27(1):79-88. 被引量:389
-
2Wolfe F.Zwillich sH.The long-term outcomes of rheumatoid arthritis:a 23-year prospective,longitudinal study of total joint replacement and its predictors in 1600 patients with rheumatoid arthritis.Arthritis Rheum.1998,41:1072-1082.
-
3Fehon DT,Anderson JJ.American College of ILheumatology preliminary definition of improvement in rheumatoid arthritis.Arthritis Rhearn,1995,38:727-735.
-
4Fex E,Jomson K,Johnson U,et al.Development of radiographic damage during the flint 5-6 yr of rheumatoid arthritis:a prospective follow-up study of a Swedish cohort.Br J Rheumatol,1996.35:1106-1115.
-
5Fuchs HA,Kaye JJ,Callahan LF,et al.Evidence of significant radiographic damagein rheumatoid arthritiswithinthefirst2 years ofdisease.J Rheumatol,1989,15:585-591.
-
6Mǒttǒnen TT.Prediction of erosiveness and rate ofdevelopment of new erosions in early rheumatoid arthritis.Ann Rheum Dis,1988.47:648-653.
-
7Brerman FM,Maini RN,Feldmann M.TNFα-a pivotal role in rheumatoid arthritis?Br J Rheumatul,1992,31:293-298.
-
8Emery P,Breedveld FC,Hau S,et al.Comparison of methotrexate monotherapy with a eombination of methotrexate and etanercept in active.early.mederate to gevere rheumatoid arthritis(COMET):a randomised,double-blind,parallel treatment trial.Lancet,2008.372:375-382.
-
9Weinblatt ME,Kremer JM,Bankhurst AD,et al.A trial of etaIlercept.a recombinant tumor necrosis factor receptor:Fc fusion protein,in patients with rheumatoid arthritis receiving methotrexato.N Engl J Med,1999,340:253-259.
-
10Maini RN,St Clair EW,Breedveld F,et al.Randomised phase Ⅲtrial of infliximub combined with ongoing methotrmmte in the treatment of rheumatoid arthritis with persistent disease activity.Lancet,1999,354:1932-1939.
共引文献2114
-
1崔朋涛,曹洋,曹玉举.寒湿痹停丸联合西药治疗寒湿痹阻证强直性脊柱炎的临床研究[J].中药药理与临床,2021,37(6):149-152. 被引量:3
-
2邓运明,谢彩妮.阿达木单抗联合三痹汤治疗寒湿型强直性脊柱炎的疗效观察[J].中医临床研究,2023,15(3):85-88.
-
3张亚楠,赵玉洲,王培培.温针灸联合痹愈汤辅治类风湿性关节炎临床观察[J].实用中医药杂志,2020(5):645-646. 被引量:2
-
4孙玄静,张秀胜.甲氨蝶呤联合益赛普对类风湿关节炎治疗的价值分析[J].中西医结合心血管病电子杂志,2019,0(36):187-187. 被引量:2
-
5王春燕.中药熏蒸治疗强直性脊柱炎概述[J].中国民族医药杂志,2023,29(7):52-54.
-
6伊力夏提·买买提,热扑开提·赛吾力丁,帕尔哈提·热甫开提,米尔佧米力·麦麦提依明,海热拉·木萨,克热木江·买买祖努库,娜迪拉·艾伯都拉.吐尔洪·艾买尔教授维医诊疗类风湿性关节炎的学术思想[J].中国民族医药杂志,2021,27(11):34-37. 被引量:1
-
7代君君,罗时昱,舒蕊,刘健,章玉萍,张丽丽,陈明,赵萍.蜂针疗法治疗强直性脊柱炎临床研究现状[J].中国蜂业,2020,0(2):47-49. 被引量:2
-
8史然然.甲氨蝶呤片联合来氟米特片对类风湿关节炎患者血清α1-AGP、RF、HMGB1的影响[J].慢性病学杂志,2023(10):1449-1453.
-
9白润娟,张晓岚,倪角角,张靓,梁丽娟.温阳通督药物罐对肾虚督寒型强直性脊柱炎体征指标及脊柱功能的影响[J].慢性病学杂志,2022(12):1805-1808. 被引量:2
-
10张满琴.祛风通痹汤联合温针灸在50例类风湿性关节炎患者中的应用效果[J].慢性病学杂志,2022(3):414-416.
同被引文献107
-
1赵慧,汪静,杨喜云,郭建,王宏沛,沈海丽.英夫利昔单抗治疗强直性脊柱炎累及颞颌关节一例[J].中华临床医师杂志(电子版),2011,5(7):2162-2163. 被引量:1
-
2张莉芸,黄烽.生物制剂治疗强直性脊柱炎研究进展[J].中华风湿病学杂志,2005,9(2):112-115. 被引量:50
-
3Listing J,Brandt J,Rudwaleit M,et al.Impact of anti-tumour necrosis factor alpha treatment on admissions to hospital and days of sick leave in patients with ankylosingspondylitis[J].Ann Rheum Dis,2004,63(12):1670-1672.
-
4Kobelt G,Andlin-Sobocki P,Brophy S,et al.The burden of ankylosing spondylitis and the cost-effectiveness of treatment with infliximab(Remicade)[J].Rheumatology(Oxford),2004,43(9):1158-1166.
-
5Fautrel B,Benhamou M,Breban M,et al.Cost effectiveness of two therapeutic regimens of infliximab in ankylosing spondylitis:economic evaluation within a randomised controlled trial[J].Ann Rheum Dis,2010,69(2):424-427.
-
6Brandt J, Haibel H, Comely D, et al.Successful treatment of active ankylosing spondylitis with the anti-tumor necro- sis factor-alpha monoclonal antibody infliximab[J]. Arthri- tis Rheum,2001,44(12) :2 936.
-
7Braun J, Baraliakos X, Golder W, et al. Magnetic reso-naace imaging examinations of the spine in patients with ankylosing spondylitis, before and after successful thera- py with infliximab: evaluation of a new scoring system[J]. Arthritis Rheum, 2003,48(4) : 1 126.
-
8Theis VS, Rhodes JM. Review article: minimizing tubercu- losis during anti-tumor necrosis factor-alpha treatment of inflammatory bowel disease[J]. Aliment Pharmacol Ther, 2008,27(1) : 19.
-
9Wolfe F, Michaud K, Anderson J, et al.Tuberculosis infec- tion in patients with rheumatoid arthritis and the effect of infliximab therapy[J]. Arthritis Rheum, 2004,50 (2) : 372.
-
10Dixon WG , Hyrich KL , Watson KD, et al.BSRBR Con- trol Centre Consortium, and DPM Symmonsl, on behalf of the BSR biologics register drug-specific risk of tubercu- losis in patients with rheumatoid arthritis treated with an- ti-TNF therapy: results from the British Society for Rheu- matology Biologics Register (BSRBR)[J]. Ann Rheum Dis, 2010,69(3) : 522.
引证文献7
-
1何江江,胡善联,茅艺伟,张崖冰,岳宁,刘蕊.英夫利西单抗治疗强直性脊柱炎的药物经济学评价[J].中国药物经济学,2015,10(4):13-15. 被引量:1
-
2冯莉霞,朱剑,张江林,黄烽,李坤鹏.英夫利西单抗治疗风湿性疾病的安全性评价[J].中国药房,2015,26(17):2356-2358. 被引量:2
-
3贺桂泉,朱铁梁,邢国胜.肿瘤坏死因子拮抗剂英夫利昔单抗临床应用研究进展[J].天津药学,2016,28(1):36-42. 被引量:7
-
4印斌.英夫利西单抗治疗类风湿关节炎患者的临床应用及安全性评估[J].中国民康医学,2016,28(5):69-70. 被引量:2
-
5吴系美,李博,佘若男,汪小平.类克治疗强直性脊柱炎的临床效果及对患者miR146a的影响[J].临床医学,2017,37(5):57-58. 被引量:3
-
6夏志高,柳彩阳.英夫利西单抗联合甲氨蝶呤治疗活动性类风湿关节炎的效果及安全性研究[J].中国当代医药,2017,24(19):151-153. 被引量:4
-
7王啸,李无阴.顽痹康丸治疗肝肾阴虚证类风湿关节炎临床观察[J].湖北中医杂志,2019,41(5):12-15. 被引量:3
二级引证文献21
-
1刘思,连鑫.肾移植术后ANCA相关性血管炎性肾炎1例[J].中国实验诊断学,2023,27(10):1224-1226.
-
2张鲁宁.益赛普治疗难治性强直性脊柱炎患者的疗效观察[J].中国民康医学,2016,28(10):34-35. 被引量:5
-
3黄淑晖,刘淮.妊娠合并类风湿性关节炎的药物治疗研究进展[J].中国妇幼保健,2017,32(9):2041-2044. 被引量:3
-
4陈禾凤,杨婉花,姚玮艳.英夫利西单抗治疗克罗恩病的疗效、安全性观察及影响因素分析[J].中国药房,2017,28(35):4947-4951. 被引量:9
-
5李晓燕,张惠琴,李辉,张艳.英夫利西单克隆抗体治疗类风湿关节炎患者血脂水平的变化[J].中国医刊,2017,52(12):42-44. 被引量:6
-
6蒋文捷.英夫利昔单抗联合组胺受体拮抗剂治疗老年类风湿关节炎疗效观察[J].现代医药卫生,2018,34(9):1327-1329.
-
7吴系美,李博,佘若男,谭锦辉,汪小平.英夫利昔单抗治疗强直性脊柱炎的疗效及对miR-146a表达的影响[J].中华实用诊断与治疗杂志,2018,32(7):701-703. 被引量:5
-
8赵磊,张智涵,赵艳霞.重症银屑病的治疗[J].中国中西医结合皮肤性病学杂志,2018,17(2):190-192. 被引量:4
-
9耿毓汕.ANCA相关性血管炎肾损伤的诊疗进展[J].中国医药导刊,2019,21(2):65-71. 被引量:7
-
10赵慧敏,高明利.从“肝肾同源”论治类风湿关节炎[J].云南中医中药杂志,2019,40(12):28-30. 被引量:6
-
1吕昊,王海明.腹腔镜手术联合中药在粘连性肠梗阻中的应用价值[J].辽宁中医杂志,2014,41(5):965-966. 被引量:3
-
2甘立新.碘盐与甲状腺机能亢进(甲亢)的思考[J].科技创新导报,2013,10(21):226-226.
-
3包曹歆.糖尿病肾病危险因素分析[J].黑龙江医学,2005,29(10):772-773.
-
4王心悦.糖尿病与非糖尿病患者发生心律失常的类型和危险因素分析[J].中国医药指南,2016,14(3):102-103. 被引量:1
-
5陈博.氯吡格雷联合阿托伐他汀钙在治疗TIA中的应用效果观察[J].中国现代药物应用,2015,9(22):114-115. 被引量:3
-
6蔡雪黎,张怀勤,林捷,黄伟剑,陈达开,计光,李海鹰,吴高俊,李晟,胡开宇.青年急性心肌梗死患者发病因素及冠状动脉造影结果分析[J].浙江医学,2007,29(8):816-818. 被引量:2
-
7蒋淑英.老年消化性溃疡的临床特点及治疗[J].医学美学美容(中旬刊),2015,24(1):187-187.
-
8邓会明.充血性心力衰竭患者血清C-反应蛋白的变化及辛伐他汀的干预作用[J].临床医药文献电子杂志,2014,1(11):1139-1139.
-
9李向东.急性重度有机磷中毒血液灌流70例临床治疗分析[J].临床医学,2015,35(3):60-61. 被引量:1
-
10马昭娟,袁建喜.急性心肌梗死临床表现与年龄的关系[J].中西医结合心血管病电子杂志,2015,3(31):6-7. 被引量:2